中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
21期
13-13,15
,共2页
酚妥拉明%小儿肺炎%临床效果%效果观察
酚妥拉明%小兒肺炎%臨床效果%效果觀察
분타랍명%소인폐염%림상효과%효과관찰
Phentolamine%Infantile pneumonia%Clinical effect%Observation
目的：探究酚妥拉明治疗小儿肺炎的临床效果。方法选取100例2013年3月至2014年3月在我院儿科就诊的确诊小儿肺炎的患儿，随机分成对照组和试验组，分别给予常规治疗和常规治疗基础上给予酚妥拉明静脉滴注治疗，比较两组的临床疗效。结果对照组患儿症状消失时间明显长于试验组患儿，住院时间也明显长于试验组患儿，试验组患儿治疗总有效率86%（43例患儿有效），明显高于对照组患儿治疗总有效率60%（30例患儿治疗有效），对照组患儿发热，呕吐，低血压等并发症发生率为18%（9例），明显高于试验组患儿并发症发生率4%（2例），均有P＜0.05，差异有统计学意义。结论酚妥拉明治疗小儿肺炎临床疗效良好，可以明显缩短病程和住院时间，提高治疗有效率，同时减少并发症的发生，建议临床上推广使用酚妥拉明治疗小儿肺炎。
目的：探究酚妥拉明治療小兒肺炎的臨床效果。方法選取100例2013年3月至2014年3月在我院兒科就診的確診小兒肺炎的患兒，隨機分成對照組和試驗組，分彆給予常規治療和常規治療基礎上給予酚妥拉明靜脈滴註治療，比較兩組的臨床療效。結果對照組患兒癥狀消失時間明顯長于試驗組患兒，住院時間也明顯長于試驗組患兒，試驗組患兒治療總有效率86%（43例患兒有效），明顯高于對照組患兒治療總有效率60%（30例患兒治療有效），對照組患兒髮熱，嘔吐，低血壓等併髮癥髮生率為18%（9例），明顯高于試驗組患兒併髮癥髮生率4%（2例），均有P＜0.05，差異有統計學意義。結論酚妥拉明治療小兒肺炎臨床療效良好，可以明顯縮短病程和住院時間，提高治療有效率，同時減少併髮癥的髮生，建議臨床上推廣使用酚妥拉明治療小兒肺炎。
목적：탐구분타랍명치료소인폐염적림상효과。방법선취100례2013년3월지2014년3월재아원인과취진적학진소인폐염적환인，수궤분성대조조화시험조，분별급여상규치료화상규치료기출상급여분타랍명정맥적주치료，비교량조적림상료효。결과대조조환인증상소실시간명현장우시험조환인，주원시간야명현장우시험조환인，시험조환인치료총유효솔86%（43례환인유효），명현고우대조조환인치료총유효솔60%（30례환인치료유효），대조조환인발열，구토，저혈압등병발증발생솔위18%（9례），명현고우시험조환인병발증발생솔4%（2례），균유P＜0.05，차이유통계학의의。결론분타랍명치료소인폐염림상료효량호，가이명현축단병정화주원시간，제고치료유효솔，동시감소병발증적발생，건의림상상추엄사용분타랍명치료소인폐염。
Objective To explore clinical effect of phentolamine for the treatment of pneumonia in children. Methods Selected 100 cases of children with pediatric pneumonia diagnosed from March 2013 to March 2014 in children 's hospital, they were randomly divided into control and experimental groups, the control group was given conventional treatment and another group was given to phentolamine infusion therapy which based on conventional treatment, the clinical efficacy of two groups were compared. Results The symptoms of children from the control group disappeared significantly longer than the experimental group’s, length of hospital stay was significantly longer than the experimental group of children, treatment of children in the test group with total efficiency 86%, significantly higher than children in the control group with total effective rate 60%(30 cases of children was valid), the incidence rate of fever, vomiting, and hypotension complication was 18%(9 cases)in the control group, that was significantly higher than the incidence of complications in children of the experimental group whose was 4%(2 cases), both P<0.05, the difference was statistically significant. Conclusion Treatment of infantile pneumonia by phentolamine has a good clinical efficacy, it can significantly shorten the course and length of stay, improve treatment efficiency, while reduce the incidence of complications, it is recommended to promote the use of phentolamine in clinical treatment of infantile pneumonia.
